In July 2018, UDG Healthcare announced the acquisitions of Create NYC and SmartAnalyst continuing the transformation of our organisation and strengthening our presence in the US. Both based in New York and dedicated to the healthcare industry, Create NYC is a disruptive creative communications agency and SmartAnalyst is a strategic commercialisation consulting and analytics business.

Create NYC offers the tactical execution of sales and marketing materials for international pharmaceutical clients. Founded in 2009 by Natalie McDonald, who remains with the company as CEO, it has built a unique, disruptive model which gives clients high-impact, on-demand, flexible marketing support with a flat fee structure.

This approach complements the more traditional agency model. The acquisition of Create NYC is in line with Ashfield’s strategy to expand into areas of differentiated but aligned adjacencies to its core scientific communication capabilities.

SmartAnalyst is a strategic consulting and analytics business focused on the pharmaceutical and biotech sector. The company was founded in 2001 and has 135 employees based across operations in New York, London and Gurgaon, India. The business provides strategic consulting services to support disease, asset and portfolio-level decisions as well as Health Economics and Outcomes Research (HEOR) services. SmartAnalyst expands Ashfield’s Advisory service proposition providing access to commercial development decision makers, as well as infrastructure in India.

The two acquisitions further expand the services we offer to healthcare clients. Create NYC adds innovative creative services within Ashfield Communications and SmartAnalyst expands Ashfield’s Advisory offering adding new capabilities in strategic consulting and the high-growth area of Health Economics and Outcomes Research.

Brendan McAtamney - Chief Executive Officer